Vicky Makker
Impact in
- Obstetrics and Gynecology top 0.1%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Endometrial and Cervical Cancer Treatments 93
- Oncology 53
- HER2/EGFR in Cancer Research 22
- Cancer Immunotherapy and Biomarkers 20
- Co-authors
- Ana Oaknin (19 shared papers)Carol Aghajanian (61 shared papers)Matthew H. Taylor (17 shared papers)Corina E. Dutcus (15 shared papers)Daniel E. Stepan (9 shared papers)Robert Shumaker (3 shared papers)Nadeem R. Abu‐Rustum (32 shared papers)Kaled M. Alektiar (30 shared papers)
- Journals
- Gynecologic Oncology (45 papers)Journal of Clinical Oncology (44 papers)International Journal of Gynecological Cancer (27 papers)Annals of Oncology (17 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Vicky Makker
168 papers receiving 4.8k citations
Vicky Makker's Hit Papers
Peers
Comparison fields: 5 of 101
- Obstetrics and Gynecology 1.9k
- Reproductive Medicine 897
- Oncology 1.5k
- Cancer Research 495
- Pulmonary and Respiratory Medicine 681
Countries citing papers authored by Vicky Makker
This map shows the geographic impact of Vicky Makker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Makker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Makker more than expected).
Fields of papers citing papers by Vicky Makker
This network shows the impact of papers produced by Vicky Makker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Makker. The network helps show where Vicky Makker may publish in the future.
Co-authors
The 25 scholars most cited alongside Vicky Makker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial Hit paper breakdown → | 2023 | 514 |
| 2 | Endometrial cancer Hit paper breakdown → | 2021 | 374 |
| 3 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Hit paper breakdown → | 2020 | 366 |
| 4 | Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 363 |
| 5 | Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2022 | 331 |
| 6 | Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors Hit paper breakdown → | 2020 | 313 |
| 7 | 2020 | 103 | |
| 8 | 2014 | 96 | |
| 9 | 2019 | 93 | |
| 10 | 2015 | 77 | |
| 11 | 2017 | 71 | |
| 12 | 2020 | 68 | |
| 13 | 2016 | 65 | |
| 14 | 2023 | 62 | |
| 15 | 2013 | 62 | |
| 16 | 2018 | 57 | |
| 17 | 2019 | 51 | |
| 18 | 2018 | 51 | |
| 19 | 2018 | 46 | |
| 20 | 2021 | 46 |
About Vicky Makker
Vicky Makker is a scholar working on Obstetrics and Gynecology, Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 183 papers that have together received 4.9k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (93 papers), Ovarian cancer diagnosis and treatment (38 papers), HER2/EGFR in Cancer Research (22 papers), Cancer Immunotherapy and Biomarkers (20 papers), Cancer Genomics and Diagnostics (12 papers), Endometriosis Research and Treatment (11 papers), Renal cell carcinoma treatment (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Obstetrics and Gynecology (1.9k citations), Reproductive Medicine (897 citations), Oncology (1.5k citations), Cancer Research (495 citations) and Pulmonary and Respiratory Medicine (681 citations). Vicky Makker has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Ana Oaknin, Carol Aghajanian, Matthew H. Taylor, Corina E. Dutcus, Daniel E. Stepan, Robert Shumaker, Nadeem R. Abu‐Rustum, Kaled M. Alektiar, Drew Rasco and Douglas A. Levine. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, International Journal of Gynecological Cancer, Annals of Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.